Nude mice have been widely used in the field of oncology, especiallyfor anticancer agent screening. The most popular strains of nude mice are BALB/c nude mice (BALB/c-nu) (Inaba et al., 1988a,b) and NIH(S)-nu (Goldin et al., 1981) . However, the productivity of BALBI c-nu is poor because of inbreeding, which makes the mice expensive. It has also been argued that inbred mice do not have a broad genetic background and, therefore, several strains of inbred mice are required for bioassays (Festing, 1975) . On the other hand, NIH(S)-nu do not have constant genetic background because of genetic drift (Rice & O'Brien, 1980) although their productivity is better than that of BALB/c-nu.
Our new stock of nude mice, AF nude mice, shows high productivity, are heterogeneous and sets of animals sharing a common gene pool can be produced because it was developed by mating 2 different inbred strains of mice (Nomura et al., 1987) . In the present study, the toxicity of anticancer agents, and the growth and chemosensitivity of human tumour xenografts in AFnu were investigated and compared with those in BALB/cA-nu to confirm the usefulness of AF-nu for anticancer agent screening.
Materials and methods

Mice
Six-to eight-week-old AF-nu and BALB/cA-nu of both sexes from CLEA Japan Inc. (Tokyo, Japan) were used. As previously reported (Nomura et al., 1987) , 3 different mating steps are required to obtain AF-nu. In the first step a female mouse of IAI strain [one of 20 inbred strains (A to T lines) originating from Jel :ICR in the Ishibe breeding colony (CLEA Japan Inc.)] is mated with a nude male (nulnu) NFS/N (from Dr Carl T Hansen, National Institute of Health, Bethesda, MD, USA), resulting in heterozygous offspring (+ nu) . In the second step heterozygous males and females are mated. In the third step male nude mice obtained from this F 2 cross are mated with heterozygous Fj female mice. BALB/cA-nu were obtained by mating homozygous (nulnu) males with heterozygous (+ Inu) females. Mice were maintained under specific-pathogen-free conditions and housed in ethylene oxide-sterilized filter -capped polycarbonate cages (3 mice per cage, at a temperature of 24-26 DC and a humidity of 60-70%). Mice were held for over a week to condition them to the husbandry condition before experimentation. 6OCo-irradiated (3 mega-rads) food pellets (CA-I, CLEA Japan Inc.) and tap water were supplied ad libitum. The cages and bedding (wood flakes) were sterilized by autoclaving. The lighting cycle was 12 h light and 12 h dark.
Anticancer agents
Vincristine (VCR), vinblastine (VLB) (both from Shionogi & Co Ltd, Osaka, Japan), bleomycin (BLM; from Nihon Kayaku Co, Tokyo, Japan) and methotrexate (MTX; from Lederle Japan Ltd, Tokyo, Japan) for clinical use were purchased. Mitomycin C (MMC), adriamycin (ADR) and 5-fluorouracil (5-FU) were kindly supplied by Kyowa Hakko Kogyo Co Ltd (Tokyo, Japan) as pure crystals for experimental use. Cyclophosphamide (CPM), nimustine (ACNU) and cisplatin (DDP) were provided by Shionogi & Co. (Tokyo, Japan) Sankyo Co. Ltd (Tokyo, Japan) and Bristol-Myers Research Institute, Ltd, (Tokyo, Japan), respectively, in 343 a form for experimental use. All drugs were dissolved in sterile 0·85% NaCl solution just before use.
Human tumour xenograft lines
Human tumour xenografts maintained by serial subcutaneous transplantation in BALB/cA-nu were used. Four xenografts (St-15, mucinous adenocarcinoma of the stomach; GL-5-JCK, glioblastoma multi forme; Lu-130, small cell carcinoma of the lung; L-27, poorly differentiated adenocarcinoma of the lung) were studied with respect to their takes and growth rates. Five xenografts (St-15; 4-1ST, poorly differentiated adenocarcinoma of the stomach; Lu-65, large cell carcinoma of the lung; L-27; GL-5-JCK) were investigated for their chemosensitivities to anticancer agents.
Toxicity assay
Five anticancer agents were given by single (ACNU, ADR and VCR) or daily injection for 5 days (5-FU and MTX) to AF-nu and BALBI cA-nu. The test doses were increased step by step at a constant multiple of 1.2. The observation periods after drug administration were 30 days except for ADR (60 days) which was reported to show delayed toxicity (Moris ada et al., 1989) . The body weights in mice were measured once or twice a week. Statistical significance of the difference in body weight change between AF-nu and BALB/cA-nu was determined by the pooled two-sided two-sample t-test.
Tumour growth rate
The tumour fragment (3 x 3 x 3 mm) was subcutaneously inoculated in the right flank of AFnu and BALB/cA-nu. After inoculation, tumour size was measured for 8 to 12 weeks. The tumour volume (V) was calculated by means of the equation: V = a X b 2 /2, where a and b are length and width in mm, respectively. Statistical significance of the difference in tumour volume between AF-nu and BALBI cA-nu was determined by the pooled two-sided two-sample t-test.
Chemosensitivity
When the tumour volume reached 100-300 mm 3 , administration of anticancer agents was started (day 0). Doses of each drug (mg/kg) were as follows (Inaba et al., 1986) : MMC, 6'7; CPM, 260; ACNU, 48; ADR, 12; VCR, 1'6; 5-FU, 19; DDP, 10; VLB, 11; BLM, 46; MTX, 15. Drugs were given intravenously by daily injection for 5 days in the case of 5-FU, BLM and MTX or by single injection for all other drugs. Observation was continued for 3 weeks. Each tumour volume was expressed as the relative tumour volume (RV) compared to that on day 0: RV= Vn/Vo where Vn is the tumour volume on day nand Vo is the initial tumour volume on day O. T /C(fl/o)was expressed as the average R V of the treated mice with respect to the control. The agents were determined as 'effective' when T/C(fl/o) was 50fl/oor less on the fourteenth day after initial treatment, and was statistically significant by the Mann-Whitney Utest (P<O'OI, one-sided) (Inaba et al., 1986) . 
Results
Toxicity
The mortality of AF-nu and BALB/cA-nu administered anticancer agents is shown in Table  I . The two strains of mice showed almost the same mortality when administered 5-FU and ACNU. In the case of ADR and MTX, the mortality of AF-nu was lower than that of BALB/cA-nu. However, with VCR, the mortality of AF-nu was higher than that of BALB/cA-nu .. Body weight changes in both strains of mice are shown in Fig. 1 . Body weight loss and recovery of nude mice administered ACNU (48 mg/kg), ADR (14·4 mg/kg) and VCR (2' 3 mg/kg) were not significantly different between AF-nu and BALB/cA-nu, but in the case of 5-FU (22' 8 and 19· 0 mg/kg), the body weight gains in AF-nu were significantly (P<0'05) less than those in BALB/cA-nu from 14 to 30 days after initial treatment.
Takes and growth rates of human tumour xenografts
All four tumour xenografts transplanted in AF-nu and BALB/cA-nu were detected as growing Week" ••ftcr trllnaplllnt ••tlon nodules. Figure 2 shows growth curves of L-27 transplanted in male and female AF-nu. There was no sex effect on growth of the tumour in AF-nu.
Growth curves of four xenograft lines in AF-nu and BALB/cAlnu are shown in Fig. 3 . There were no differences in growth curves of St-15 and GL-5-JCK between the 2 strains of nude mice, but the growth of Lu-130 and L-27 in AF-nu were more rapid than those in BALB/cA-nu in the later stages after transplantation. The range of tumour volumes of St-I5 and GL-5-JCK in AF-nu was slightly wider than those in BALB/cA-nu, but those of L-27 and Lu-130 in AF-nu were similar to those in BALB/cA-nu.
Chemosensitivity of xenografts
Evaluation of sensitivities of 5 xenografts to ten agents is shown in Table 2 . There was no sex difference in AF-nu for MMC, ACNU and ADR against St-15, and for VCR and VLB against L-27.
Although chemosensitivities of St-15, 4-1ST and GL-5-JCK were entirely consistent between AF-nu and BALB/cA-nu, strain differences in chemosensitivity were noticed in the ACNU and DDP administered groups for Lu-65, and in the MMC, CPM and ADR administered groups for L-27. The T IC(OJo)values in AF-nu and BALBI cA-nu, respectively, were 48 and 13% in the ACNU and 52 and 37% in the DDP for Lu-65; and 41 and 52% in the MMC, 49 and 57% in the CPM, and 43 and 59% in the ADR for L-27. The total consistency rate of chemosensitivities of 5 xenografts evaluated by our criteria was 88% (38/43).
Discussion
Although human-tumour-bearing nude mice have been widely used in recent years as an in vivo drug screening system (Goldin et al., 1981; Inaba et al., 1988a,b) , there are only a few reports on nude mice (Maruo et al., 1982; Sudo et al., 1989) suitable for anticancer agent screening and experimental chemotherapy, the fields requiring the greatest numbers of nude mice. In the present study, a new stock of nude mice (AF-nu) developed by us was tested with respect to the toxicity of anticancer agents, growth and chemosensitivity of transplanted human tumour xenografts. The data obtained with AF -nu were compared with that from the widely used BALB/cA-nu.
From the results on toxicity, AF-nu were more resistant to MTX than BALB/cA-nu which is preferable because the drug concentrations of 
..,;.
..J oJ 0 5-FU and MTX in the blood ofBALB/cA-nu given the maximum tolerated doses were lower than those of humans and the effects of these drugs have been underestimated in nude mice (Inaba et al., 1988a) . The reason why the greater body weight recovery of AF-nu than BALB/cA-nu given 5-FU was statistically significant is not clear. Although growth rates of 2 xenografts were not significantly different between the 2 nude mouse strains, the more rapid growth in the late stage of 2 human lung tumour xenografts in AFnu than in BALB/cA-nu may be related to genes introduced from NFS/N-nu which shows better tumour growth (Maruo et al., 1982) . The range of tumour volumes in AF-nu and BALB/cA-nu were not markedly different and irregular tumour growth due to the genetic heterogeneity of AF-nu was not observed as occurs in NIH(S)nu (Maruo et al., 1982) . The reason may be that the genetic background of AF-nu is broad but limited to variability existing between the two inbred strains used for the production of AF-nu while NIH(S)-nu is genetically variable as shown by biochemical genetic monitoring (Rice & O'Brien, 1980) . Although chemosensitivities in AF-nu were in good agreement with those in BALB/cA-nu, there were some differences between AF-nu and BALB/cA-nu. However, these differences in chemosensitivity are very slight and the T 1C(llJo) values were almost all about 500,10. The different evaluations may be due to our criteria which considered Tie 500,10as a borderline value between 'effective' and 'ineffective' rather than the strain dependency of mice.
From these results and the previous report which indicated that AF-nu has higher reproductivity, genetic heterogeneity and is potentially genetically repeatable (Nomura et al., 1987) , it is suggested that AF nude mice are more useful than BALB/cA-nu for anticancer agent screening and experimental chemotherapy.
